Consilium Strategic Communications has been selected by Vectura to advise on its international financial and corporate PR dealings, following the completion of its £441m merger with SkyePharma.
The London-based healthcare strategic communications will work with Vectura as it implements its business plan to become an industry-leading respiratory specialist, under the purview of former AstraZeneca executive James Ward-Lilley.
Consilium’s Mary-Jane Elliott, Susan Stuart, Jessica Hodgson, Chris Welsh and Melissa Gardiner will have central roles in directing Vectura’s PR strategy.
Commenting on the partnership, co-founder managing partner of Consilium Elliot said: “We are delighted to be working with Vectura during such an exciting time for the company and since its merger with Skyepharma.
“Vectura aims to establish its position as the new UK-based international inhaled airways disease-focused powerhouse and we look forward to helping them build the new Vectura story.”